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CpG content affects gene silencing in mice: evidence from novel transgenes Transgenes are often engineered using regulatory elements from distantly related genomes. Although correct expression patterns are fre- quently achieved even in transgenic mice, inappropriate expression, especially with promoters of widely expressed genes, has been  reported. DNA methylation has been implicated in the aberrant expression, but the mechanism by which the methylation of a CpG-rich  sequence can perturb the functioning of a promoter is unknown. 
Abstract
Background: Transgenes are often engineered using regulatory elements from distantly related
genomes. Although correct expression patterns are frequently achieved even in transgenic mice,
inappropriate expression, especially with promoters of widely expressed genes, has been reported.
DNA methylation has been implicated in the aberrant expression, but the mechanism by which the
methylation of a CpG-rich sequence can perturb the functioning of a promoter is unknown.
Results: We describe a novel method for analyzing epigenetic controls that allows direct testing
of CpGs involvement by using LacZ reporter genes with a CpG content varying from high to zero
that are combined with a CpG island-containing promoter of a widely expressed gene - the α-
subunit of the translation elongation factor 1. Our data revealed that a LacZ transgene with null
CpG content abolished the strong transgene repression observed in the somatic tissues of
transgenic lines with higher CpG content. Investigation of transgene expression and methylation
patterns suggests that during de novo methylation of the genome the CpG island-containing
promoter escapes methylation only when combined with the CpG-null transgene. In the other
transgenic lines, methylation of the promoter may have led to transcriptional silencing.
Conclusions: We demonstrate that the density of CpG sequences in the transcribed regions of
transgenes can have a causal role in repression of transcription. These results show that the
mechanism by which CpG islands escape de novo methylation is sensitive to CpG density of adjacent
sequences. These findings are of importance for the design of transgenes for controlled expression.
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Background
Methylation of cytosine residues of the CpG dinucleotides of
DNA constitute the basis of an epigenetic control of gene
expression in vertebrate animals [1,2]. Genomic methylation
patterns are of critical importance in various biological proc-
esses such as silencing of parasitic elements, development,
tumorigenesis and genomic imprinting [3-5]. In the genome,
CpGs are not uniformly distributed: the average level is only
1% and there are about 30,000 short regions rich in CpGs [6].
Frequently, the promoters of widely expressed genes are
included in a CpG island whereas promoters of strictly
expressed genes generally are not [7]. In mammals, DNA
methylation patterns are established by two distinctive DNA
cytosine methyltransferases, Dnmt3a and Dnmt3b, during
development after implantation [8]. DNA methylation is then
maintained by another methyltransferase, Dnmt1 [9]. CpG
islands remain unmethylated; their aberrant methylation
results in the silencing of their expression. Methylation of
promoters does not lead to silenced transcription until chro-
matin proteins are recruited to the region [10]. Methyl cyto-
sine binding proteins (MBPs), associated with 5meCpG and
also part of complexes that contain histone deacetylases
(HDACs), are involved in silencing. Dnmts also associate with
HDAc as well as with HP1 [11]. The DNA of these silent
regions is packaged into nucleosomes that contain
deacetylated histone H3 [2,12].
Effects that spread in cis have been demonstrated at two lev-
els in this process. De novo methylation can spread from
regions that serve at foci [13]. Methylation of non-promoter
sequences can result in transcriptional silencing of a reporter
gene [10,14]. Diffusion of gene silencing involves histone
deacetylation as well as structural and remodeling activities
of chromatin [15]. The mechanisms underlying these effects
in cis are not understood. If both methylation and the effects
of methylation can diffuse in cis, the questions of how CpG
islands escape methylation when adjacent sequences are
hypermethylated, and how the resident promoter escapes
silencing, are clearly posed. It could be that boundary ele-
ments delimit domains allowing them to maintain different
states [16]. Alternatively, proteins such as CpG-binding pro-
teins [17], which bind unmethylated DNA, are potential can-
didates for maintaining hypomethylation of CpG.
These issues are important for understanding the functional
organization of the genomes. They are also important when
designing artificial genes from sequences of distant origin. In
fact it is remarkable that the CpG-rich bacterial sequences
associated with eukaryotic control elements are functional.
However, there are cases where expression is not faithfully
reproduced. This is almost always the case with the associa-
tion of bacterial sequences with promoters of widely
expressed genes [18-22]. This could be due to the absence of
required enhancers or Locus control region (LCR) elements or
to their association with the bacterial sequences. In one case it
was shown that the rewriting of the sequences of a bacterial
gene was beneficial for its expression in transgenic mice [23].
To evaluate the significance of global CpG content in epige-
netic controls, we constructed LacZ genes differing only in
their CpG content, from high density to null [24]. These mol-
ecules were combined with promoters of widely expressed
genes - promoters that generally do not reproduce a wide-
spread expression pattern when used in transgenesis. We
show that a complete repression of the CpG-rich LacZ trans-
gene is observed even at single copy in all somatic tissues
whereas widespread expression is obtained with the LacZ
transgene lacking CpG. Methylation studies suggest that the
mechanism by which this effect is mediated involves interfer-
ence between the protection of a CpG island from de novo
methylation and the de novo methylation of the adjacent
sequences during development.
Results
Two novel reporter genes: LagZ and LagoZ
Two novel reporter genes, LagZ and LagoZ, were derived by
directed mutagenesis of the LacZ gene which has a CpG con-
tent of 9.24% (291 CpG for 3,076 bp, Figure 1a,b), which cor-
responds in density to CpG-rich regions of the vertebrate
genome. LagZ (Figure 1c) and LagoZ (Figure 1d) have CpG
densities of 1.6% (50% above CpG-poor regions in verte-
brates) and 0.06% (2 CpG), respectively. Through use of
alternate codons, each modified codon encodes the same
amino acid as LacZ [24]. A few non-conservative mutations
have appeared during the mutagenesis in LagoZ [24]. As we
restricted the modification to CpG sequences, the AT content
of the three DNA molecules remained almost the same
(44.2%, 50.7% and 51.8%, respectively) and the differences in
codon usage were minimal. We chose this approach, rather
than a general re-encoding of LacZ with preferred mamma-
lian codons, to test unambiguously the differences in trans-
gene behavior resulting from changes in CpG content alone.
These genes were attached to the same control elements,
which included a 2.3 kb fragment of the human promoter of
the α-subunit of the elongation factor 1 of translation (EF1α)
[25]. This promoter possesses the characteristics for widely
expressed genes in particular and it is included in a CpG
island with a CpG content of 6.2% (Figure 1). The reporter
gene was placed in exon 2 at 160 bp from the end of the CpG-
rich island. We chose widely expressed genes as it is particu-
larly with ubiquitous promoters that transgenes have failed to
reproduce correct expression patterns, despite many
attempts [18,19,21]. The expression potential of these three
transgenes was analyzed in vivo through the creation of
transgenic mice. The testing of these transgenes in animals
(as opposed to cultured cells) permitted analysis of transgene
expression at multiple periods of development and in multi-
ple cell types: here, during gametogenesis and at the blasto-
cyst stage, when the genome is hypomethylated, and afterhttp://genomebiology.com/2003/4/9/R53Genome Biology 2003,     Volume 4, Issue 9, Article R53       Chevalier-Mariette et al.R53.3
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embryonic day 9.5 (E9.5), when the genome of somatic cells
is hypermethylated [26,27].
Expression studies of EF1αLacZ, EF1αLagZ and 
EF1αLagoZ in transgenic animals
In all four LacZ (Figure 2i,j,m), four LagZ (Figure 2k,n) and
four LagoZ (Figure 2l,o) transgenic lines, the male germ cells
expressed the transgenes. Expression includes type A sper-
matogonia (SpA), the small chains in Figure 2m-o. Therefore,
the alteration of CpG density in the LagZ and LagoZ
sequences had no gross consequence on expression in these
cells. The quantitative expression of the three transgenes
microinjected in 1-cell stage embryo was also indistinguisha-
ble (5.6, 5.7 and 7.1 × 10-5 U β-gal, respectively, for LacZ,
LagZ and LagoZ). Together, these observations suggest com-
parable RNA stability and minimal effects of codon usage on
gene expression between the three molecules.
In contrast, dramatic differences were observed in the
embryo between the three transgenes (see Figure 2a-d for
representative examples, and Table 1). A systematic, high
expression of the LagoZ transgene was always observed in
embryonic and extra-embryonic tissues whatever the line (n
= 4) (Figure 2d,h), whereas no expression of the LacZ trans-
gene was observed (n = 4) (Figure 2b,f) and only a variegated
expression was observed in one LagZ line (n = 4)
(EFIαLagZ2, Figure 2c,g). Following differentiation of cell
types, for example at P7, these differences in transgene
expression were maintained (Table 1). Clearly, epigenetic
controls are imposed early on the LacZ and LagZ transgenes,
and cell differentiation does not erase these controls.
To test when this epigenetic control is imposed on the LacZ
and LagZ transgenes, β-galactosidase (β-gal) expression was
searched for in blastocysts. Both LacZ and LagZ transgenes
are strongly expressed in the ICM (inner cell mass) and tro-
phectoderm (Figure 2q,r) in the four EF1αLac and four
EF1αLag transgenic lines. Therefore, the epigenetic control is
imposed on the genome after the blastocyst stage but before
E9.5. Altogether, these results show that the high density of
CpGs in the transcribed region of LacZ is the cause of total
repression of its expression in somatic cells. A low density of
CpGs (LagZ gene), although higher than the corresponding
sequences in EF1α gene, still provoked a total repression or,
at best, a variegated expression in tissues included in the
widespread expression pattern of the EF1α promoter. An
absence of CpG sequences in the transcribed part of the gene
(LagoZ) resulted in a complete release from this repression.
Expression studies of single-copy YacEF1αLacZ 
transgenic animals
Some epigenetic controls are especially effective on repeated
sequences in the genome [28]. However, the study of four
YacEF1αLacZ transgenic mice (Figure 1a) in which the trans-
gene is at single copy indicated that, even in this condition,
the CpG content of the transcribed region caused total repres-
sion. The expression pattern is indistinguishable from the
expression pattern of EF1αLacZ: no expression of the LacZ
transgene in embryonic and extra-embryonic tissues and no
expression at P7 (Table 1, n = 5). As for EF1αLacZ, the male
germ cells and the cells at the blastocyst stage (Figure 2p)
expressed the transgene.
EF1αLacZ reporter genes with different CpG content Figure 1
EF1αLacZ reporter genes with different CpG content. All four constructs share the same promoter region (EF1) from the human EF1α (translation 
elongation factor 1, α subunit) gene including the exon 1 (e1) and a part of exon 2 (e2), a polyadenylation sign (poly(A)) from Moloney murine virus and a 
nuclear locating signal (nls) from the large T antigen of SV40 [32]. Both the left and right arms of the YAC (green line) are 60-70 kb long. Each vertical bar 
corresponds to a CpG dinucleotide. The percentage of CpGs in the reporter gene is indicated on the right.
9.24% CpG 
  EF1 nlsLacZ poly(A)
e2 e1
EF1 nlsLagZ
e1 e2
9.24% CpG  EF1αLacZ
 
1.6% CpG  EF1αLagZ
poly(A)
e1 e2
EF1  nlsLagoZ
0.06% CpG  EF1αLagoZ
poly(A)
1 kb
e1 e2
YACEF1αLacZ
EF1 nlsLacZ 60-70 kb poly(A) Lys 60-70 kb
(a)
(b)
(c)
(d)R53.4 Genome Biology 2003,     Volume 4, Issue 9, Article R53       Chevalier-Mariette et al. http://genomebiology.com/2003/4/9/R53
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Reduced CpG content in LacZ abolishes gene silencing in somatic tissues Figure 2
Reduced CpG content in LacZ abolishes gene silencing in somatic tissues. (a-h) YacEF1αLacZ, EF1αLacZ, EF1αLagZ and EF1αLagoZ transgene expression 
in E9.5 representative postimplantation embryos: (a-d) in toto X-gal stained E9.5 embryos, (e-h) 20 µm   cryostat sections at the level of the anterior CNS. 
(a,e) YacEF1αLacZ1, (b,f) EF1αLacZ2, (c,g) EF1αLagZ2 and (d,h) EF1αLagoZ1 transgenic lines. (i-o) Transgene expression in testis, in toto X-gal staining of 
the seminiferous tubules: (i-l) general view, (m-o) sectors with type A spermatogonia. (i) YacEF1αLacZ1, (j,m) EF1αLacZ2, (k,n) EF1αLagZ2 and (l,o) 
EF1αLagoZ1 transgenic lines. (m-o) β-gal+ type A spermatogonia (SpA). (p-r) Expression patterns at the blastocyst stage: (p) YacEF1αLacZ1, (q) 
EF1αLacZ2 and (r) EF1αLagZ2 blastocysts X-gal stained. Trph, trophectoderm; ICM, inner cell mass.
YacEF1αLacZ1 EF1αLacZ2 EF1αLagZ2 EF1αLagoZ1
YacEF1αLacZ1 EF1αLacZ2
SpA
SpA
SpA
Trph
ICM
Trph Trph
ICM
ICM
EF1αLagZ2 EF1αLagoZ1
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
(m) (n) (o)
(p) (q) (r)http://genomebiology.com/2003/4/9/R53 Genome Biology 2003,     Volume 4, Issue 9, Article R53       Chevalier-Mariette et al. R53.5
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The methylation patterns of LacZ, LagZ and of the 
promoter-containing EF1α sequences
This repression by CpG sequences is likely to be due to their
methylation, but there are several possible hypotheses to
explain the role of methylation. For instance, the methylation
of the reporter gene alone can by itself provoke a change in
chromatin structure of the adjacent promoter leading to its
silencing, an idea compatible with the fact that the promoter
included in a CpG island must escape methylation. Alterna-
tively, direct methylation of the promoter can be necessary to
repress the transgenes. To test these hypotheses, the methyl-
ation patterns of EF1αLacZ and EF1αLagZ, following diges-
tion of DNA by MspI or HpaII, were analyzed in the liver, skin
and brain as these tissues exhibit a high β-gal+ activity in the
EF1αLagoZ line (Table 1). We present the methylation pat-
terns of the lines harboring the lowest copy number. Indeed,
the presence of multiple copies in the other lines makes it
impossible to correlate expression and methylation. What-
ever the tissue or the line analyzed, all HpaII sites (13 for
LacZ, four for LagZ) were found to be methylated in 90% to
100% of the LacZ  and  LagZ  fragments of β-gal-
YacEF1αLacZ1, EF1αLacZ2 or EF1αLagZ1 lines (Figure 3a,
lanes 2, 5 and 8, and data not shown, n = 5). Therefore, it is
clear that the CpG-rich LacZ sequences are not recognized by
the cells as CpG-rich islands as they are not protected from de
novo methylation. Although these observations are compati-
ble with the idea of an indirect repression of the reporter gene
by methylated CpG, examination of the DNA of the β-gal+
Table 1
Summary of LacZ expression pattern in transgenic animals
YAC EF1αLacZEF1αLacZEF1αLagZEF1αLagoZ
Line (number of copies) 1
(1)
2
(1)
3
(1)
4
(2)
5
(1)
1
(N)
2
(6)
3
(N)
4
(N)
1
(>6)
2
(2)
3
(5)
4
(N)
1
(2)
2
(10-20)
3
(N)
4
(10-20)
Germ cells
(pachytene)
M a l e +++++ +++ + + +++ + + + +
F e m a l e +++++ +++ + + +++ + + + +
Mid-gestation
embryo (E9.5)
- - - - - - PD PD - + + PD PD + + + +
P7 CNS - - - - - - - - - + + + - + + + +
E p i is d e r m ----- --- - ++-- + + + +
Heart auricle - - - - - - - - - + + - - + + + +
H e a r t ----- --- - ++ +- + + + +
Endothelial cells----------+--++++
Liver - - - - - - - - - + + - - + + + +
L u n g ----- --- - -+-- + + + +
Spleen - - - - - - - - - + + - - + + + +
T h y m u s ----- --- - -+-- + + + +
Skeletal muscle - - - - - - - - - - + - - + + + +
Tendon cells - - - - - - - - - - + - - + + + +
Adults CNS - - - - - - - - - + + + - + + + +
E p i is d e r m ----- --- - -+-- + + + +
Heart auricle----------+--++++
H e a r t ----- --- - -+-- + - - -
Endothelial cells - - - - - - - - - - + - - + + + +
Liver - - - - - - - - - - + - - + + + +
L u n g ----- --- - -+-- + + + -
Spleen - - - - - - - - - - + - - + + + +
Skeletal muscle - - - - - - - - - - - - - - - - -
Tendon cells - - - - - - - - - - + - - + + - +
+, β-galactosidase positive; -, β-galactosidase negative; N, number of copies >20; PD, position (integration site) dependent pattern of expression. 
Expression pattern is variegated in EF1αLagZ2 line.R53.6Genome Biology 2003,     Volume 4, Issue 9, Article R53       Chevalier-Mariette et al.http://genomebiology.com/2003/4/9/R53
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EF1αLagZ2 mice indicated that, at least in this case, the
repressive effect could not be attributed solely to methylation
of the reporter sequences. Indeed, in these β-gal+ mice, the
LagZ gene was fully (100%) methylated (Figure 3a, lane 11).
If the methylation of the CpGs of the reporter gene is not suf-
ficient to repress the transgene, is the methylation of the pro-
moter sequences contained in a CpG-rich island involved? To
address this issue we examined the two HpaII DNA frag-
ments specific to this region: the 166 bp fragment and the 167
bp fragment, and the combined 333 (166 + 167) bp EF1α frag-
ments, the latter indicating partial methylation (Figure 4c).
Surprisingly, we observed complete methylation of these
sequences in β-gal- YacEF1αLacZ1 tissues (Figure 4a, lane 1,
and data not shown, n = 3, the absence of both the 170 bp and
the 333-bp-long fragments) and low levels of methylation in
β-gal- EF1αLacZ2 and EF1αLagZ1 tissues (Figure 4a, lanes 3
and 5, n = 2). Therefore, methylation of the EF1α promoter
sequences could explain the β-gal- phenotype. Other observa-
tions reinforced this possibility: in the variegated β-gal+
Methylation of reporter sequences of the genomic DNA extracted from tissue of animals hemizygous for the transgene Figure 3
Methylation of reporter sequences of the genomic DNA extracted from tissue of animals hemizygous for the transgene. DNA was extracted from (a) liver 
and (b) testis. (c) DNA was digested with the enzyme indicated under the blots: EcoRI (E) for YacEF1αLacZ and EF1αLacZ liberating a 3.1-kb-long 
fragment; EcoRI and BamHI (B) for EF1αLagZ liberating a 3.4-kb-long fragment and EF1αLagoZ liberating a 3.5-kb-long fragment. Each vertical bar 
corresponds to an HpaII/MspI site. Probes are the complete reporter gene (Pr). For EF1αLagZ the EcoRI-BamHI-MspI digestion liberates one rearranged 
fragment indicated by a purple asterisk. The reference of the transgenic line is indicated at the top.
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EF1αLagZ2 mice, EF1α promoter sequences are only partially
methylated, in contrast with β-gal- EF1αLagZ1 (Figure 4a,
lanes 7 and 5: the 170-bp-long band); in EF1αLagoZ1 mice,
EF1α promoter sequences are not methylated at all (Figure
4a, lane 9: the 170-bp-long fragment).
The examination of other HpaII sites in the CpG island dem-
onstrated additional differences between the EF1αLagoZ1
line and the LagZ and LacZ lines. The 626-bp-long fragment
in Figure 4a is indicative of the methylation of sites in the first
exon and in the first intron of EF1α (Figure 4c; the 5'HpaII
fragments in EF1αLacZ2, EF1αLagZ1, EF1αLagZ2 and
EF1αLagoZ1 transgenic lines are longer than 626 bp). This
fragment is fully detected in the EF1αLagoZ1 line (Figure 4a,
lane 9) but only partially present or absent in LagZ and LacZ
lines (Figure 4a, lanes 1, 3, 5 and 7, and data not shown, n =
6). Therefore, although the CpG island remains fully pro-
tected from methylation when combined with a LagoZ trans-
gene (depleted of CpGs) it is only partially protected (at least
when at low copy number, as in EF1αLagoZ1) or not protected
at all when it is combined with CpG-containing sequences.
These results show firstly that β-gal- phenotypes correlate
with the methylation of EF1α promoter sequences (n = 5),
and β-gal+ phenotypes with an absence of methylation of
these sequences (n = 2); and secondly that the methylation of
Correlation between an absence of methylation within the EFIα promoter and expression Figure 4
Correlation between an absence of methylation within the EFIα promoter and expression. Methylation of EF1α sequences of the genomic DNA extracted 
from (a) liver and from (b) testis of animals hemizygous for the transgene. DNA was digested with XhoI, which recognizes one site in the transgene and 
one site in the integration locus (X) (except for the YacEF1αLacZ, for which the two XhoI are in the transgene) and with HpaII or MspI as indicated at the 
top. The XhoI-MspI digestion liberates a 626-bp-long fragment indicative of sites within the first intron and exon of EF1α and two 166 and 167-bp-long 
fragments indicative of sites within the promoter region. The reference of the transgenic line is indicated at the top. (c) All four EF1α reporter genes 
constructs share the same promoter region and the exon 1 (e1), the intron 1 and a part of exon 2 (e2) of EF1α. Each vertical bar corresponds to an HpaII 
(MspI) recognition site. Pp, EF1α probe.
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the EF1α CpG-rich sequences is not observed when the
reporter gene can not be methylated (EF1αLagoZ1 line),
indicating that, in this case, the CpG-rich island is protected
from methylation. Thirdly, the results show that partial or
complete methylation of this CpG island occurs when it is
combined with CpG-rich sequences (LacZ or LagZ, n = 5)
suggesting that, in this case, the CpG-rich island is not com-
pletely protected from methylation.
Expression and methylation patterns of YacEF1αLacZ, 
EF1αLacZ and EF1αLagZ in the male germ line
The expression patterns of YacEF1αLacZ, EF1αLacZ and
EF1αLagZ suggest that inappropriate methylation of EF1α
occurs during the period of de novo methylation of the
genome after implantation of the embryo but before E9.5.
Indeed, in all three cases the blastocysts (E4.5) of these lines
strongly express the transgene (n = 13, Figure 2p-r) but the
embryos at E9.5 and subsequent stages do not (Figure 2a-d, n
= 12 out of 13). Two other observations support this conclu-
sion. Firstly, the absence of methylation of the EF1α CpG
island in YacEF1αLacZ1, EF1αLacZ2 and EF1αLagZ2 DNA in
the male germ line (Figure 4b, lanes 1, 3 and 5: the presence
of the 170 and 626-bp-long fragments, and data not shown, n
= 5) and also, as expected, in EF1αLagoZ1 (Figure 4b, lane 7).
Secondly, the lower methylation level of the LacZ reporter
sequences in this tissue when compared to somatic tissues
(Figure 3b, lanes 2 and 5).
These observations also confirm that, as in the somatic tis-
sues of EF1αLagZ2, a methylated LagZ reporter gene can cor-
respond to a β-gal+ tissue (Figure 3b, lane 8). This situation
also applies to LacZ reporter genes, as a significant fraction of
the male germ cells harbor completely methylated LacZ
reporters in EF1αLacZ2 (Figure 3b, lane 5, indicated by the
arrowhead). Clearly, as in somatic tissues in the male germ
line, the mere methylation of LagZ or LacZ is not sufficient to
repress EF1α.
Discussion
We demonstrated that the density of CpG sequences in the
transcribed regions of transgenes can have a causal role in the
repression of transcription. The threshold density of CpG
sequences required to initiate repression has not yet been
determined, but repression is evident even when the CpGs are
dispersed in the sequence and at a density just above that
observed in the vertebrate genome (the EF1αLagZ lines).
Therefore, we speculate that the distribution of CpG
sequences within endogenous genes is adjusted, at least in
part, as an adaptation to this potential repression.
Our results also clearly indicate that the CpG-rich LacZ
sequences are not recognized as a CpG-rich island as they
become hypermethylated (n = 5). Therefore, mere CpG con-
tent of a sequence is not sufficient to signal it as a CpG island.
The additional cis signal(s) and trans factor(s) involved have
yet to be determined. Although still hypothetical, our results
raise the possibility that among the 30,000 CpG-rich
sequences of the mouse genome some may not be true CpG
islands and therefore may influence expression of adjacent
genes.
One way of explaining the repression of transgene expression
by the methylation of CpGs is to postulate a global change in
chromatin structure spreading in the unmethylated promoter
[1,11,15]. This mechanism could be part of the repression
observed with LacZ in somatic tissues as these sequences are
hypermethylated, and since we did not observe repression
without methylation of this sequence. However, this does not
explain why certain LagZ lines express the transgene in
somatic tissues even though LagZ is fully methylated, and
why EF1αLagZ and EF1αLacZ mice express the transgene in
the germ line even though LagZ and LacZ are also fully meth-
ylated in these cases.
An important observation made in this study suggests
another hypothesis. The EF1α DNA fragment contains a CpG-
rich island (in which the promoter region is included) which
is expected to escape de novo methylation. We found that this
is indeed the case when combined with LagoZ sequences that
cannot be methylated (the EF1αLagoZ1 line) but that the pro-
tection is less perfect when combined with ones that can be
methylated. In this case, the EF1α DNA fragment is found to
be methylated; therefore, the island is imperfectly protected
from methylation (n = 6). According to these facts, a simple
hypothesis for the mechanism of repression of transgenes by
CpG-rich sequences can be proposed: these sequences could
provoke the methylation of the adjacent sequences, which
consequently could adopt a compact chromatin structure
incompatible with transcription. It is interesting to note that,
nevertheless, the relative protection of the EF1αLacZ
sequences and the total protection of EF1αLagoZ1 indicate
that the cis element(s) which signal the EF1α sequences as a
CpG-rich island are present in the 2.3 kb sequences used in
our study, and that they function in many integration sites.
Analysis of the expression patterns of LacZ and LagZ genes
then suggest that this inappropriate methylation of the CpG
island occurs during the period of de novo methylation of the
genome, shortly after implantation of the embryo [8]. Indeed
the LacZ transgenes, EF1αLacZ and YacEF1αLacZ, are
expressed in blastocysts and are completely repressed after
implantation   at   E9.5   (n   =   12).   As   it   seems   unlikely   that
sequences essential for protection against methylation are
missing in the 2.3 kb EF1α fragment, we suggest that there is
probably interference between the mechanism of protection
of the CpG-rich island and the de novo methylation of LacZ.
It should be noted that this interference does not correspond
to an 'all-or-none' phenomenon as the individual EF1α DNA
sequences are diversely methylated, even in the same mice.http://genomebiology.com/2003/4/9/R53 Genome Biology 2003,     Volume 4, Issue 9, Article R53       Chevalier-Mariette et al. R53.9
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It is possible to speculate on the sequence of events leading to
the methylation of EF1α. We propose that at the time of de
novo methylation of the DNA, the CpG island is in a special
chromatin structure, which may be due to fixation of proteins
such as CpG-binding proteins which protect from methyla-
tion [17] (Figure 5a). The de novo methylation of the CpG-rich
adjacent sequences (Figure 5b) will then lead to a change of
conformation of the EF1α region (Figure 5c), which in turn
will lead to the methylation of a few of its CpGs (Figure 5d). In
the absence of this change of conformation (that is, the
EF1αLagoZ case) the EF1α sequences will remain unmethyl-
ated. Alternatively, the de novo methylation of LacZ  may
spread in the adjacent CpG-rich island because of specific
properties of the methylation complex. The EF1αLagZ (β-
gal+) represents an intermediary situation suggesting a dose
effect. Finally, in relation with the level of methylation of the
EF1α sequences, the transgene will adopt a more or less com-
pact chromatin structure allowing transcription or silencing
the transgene (Figure 5e). With the CpG-free LagoZ
sequences, the EF1α sequences could escape methylation, like
the endogenous gene, and the transgene could adopt an open
chromatin structure.
Apart from improving our understanding of transcriptional
regulation in vivo, these results are of importance for the
design of transgenes for controlled expression. CpG density is
shown to be an important factor for the normal action of the
mechanism through which CpG islands escape methylation.
It is likely that many engineered genes are not adjusted to an
optimal CpG density and are subjected to partial or total
repression and/or are very susceptible to inactivation over
time. To avoid these potential effects of CpG sequences, we
propose the removal of all CpGs of the transcribed part of
transgenes (employing alternate codons), as we have demon-
strated that the absence of this dinucleotide largely eliminates
repressive effects. Other experiments are in progress to deter-
mine whether the repressive effect of CpGs can be generalized
to certain categories of genes with restricted patterns of
expression like, for example, those with a CpG island located
in their transcription start (61% of tissue-restricted genes)
[7].
Conclusions
To evaluate the significance of global CpG content in epige-
netic controls, we constructed LacZ genes differing only in
Model for the molecular mechanism of gene silencing mediated by DNA methylation of transcribed regions of a gene Figure 5
Model for the molecular mechanism of gene silencing mediated by DNA methylation of transcribed regions of a gene. (a) Before de novo methylation (at 
the blastocyst stage), EF1α and (maybe) the reporter gene are unmethylated. (b) During de novo methylation by the Dnmts, the reporter gene is 
methylated as it does not correspond to a protectable CpG-rich island. In contrast, the EF1α CpG-rich island is protected from methylation as it is in a 
special chromatin structure (the waves). (c) The partners of Dnmts and MBD induce a change of chromatin structure in EF1α (the modified waves). This 
may be involving methylated histones and/or HP1. (d) This change of chromatin structure interferes in part with the protection of the EF1α CpG-rich 
against CpG methylation. The degree of the interference is in relation with the density of methylation of the reporter gene (compare LacZ and LagZ [β-
gal+]). (e) Chromatin conformation and transcription of the transgene in somatic tissue.
YacEF1αLacZ, EF1αLacZ
or EF1αLagZ (β gal−)
EF1αLagoZ
 
EF1αLagZ (β gal+)
Methylated CpG Silencing and CpG island, change of conformation
Reporter sequences Transcription CpG island, special chromatin structure
(a)
(b)
(c)
(d)
(e)R53.10 Genome Biology 2003,     Volume 4, Issue 9, Article R53       Chevalier-Mariette et al. http://genomebiology.com/2003/4/9/R53
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their CpG content, from high density to null [24]. These mol-
ecules were combined with promoters of widely expressed
genes; promoters which generally do not reproduce a wide-
spread expression pattern when used in transgenesis. We
showed that a complete repression of the CpG-rich LacZ
transgene is observed even at single copy in all somatic tis-
sues whereas widespread expression is obtained with the
LacZ transgene lacking CpG (the LagoZ construct). Methyla-
tion studies suggest that the mechanism by which this effect
is mediated involves interference between the protection of a
CpG island from de novo methylation and the de novo meth-
ylation of the adjacent sequences.
Materials and methods
Directed mutagenesis of LacZ
The CpG content of the LacZ plasmid was first lowered from
9.24% to 1.65% to generate the PytknlsLagZ plasmid and
PytknlsLagZ was used as a template to lower the CpG content
to 0.06% to generate PytknlsLagoZ. In Pytk plasmids, a bac-
terial promoter allowed an expression screening of the muta-
genized genes in LacZ-defective bacteria (∆-Lac). To construct
LagZ and LagoZ, a polymerase chain reaction (PCR) tech-
nique was used in which the mutagenic oligonucleotide prim-
ers spanned the whole sequences but contained fewer CpG
dinucleotides. These mutagenic primers were designed to
preserve the integrity of the amino-acid sequence of the β-
galatosidase reporter protein. After each run of PCR the DNA
was purified, circularized and transfected in ∆-Lac bacteria to
select the clones presenting β-galactosidase activity. The DNA
sequences of LagZ and LagoZ were verified by sequencing
[24].
The three versions of LacZ were associated to the promoter
region of the human EF1α gene to generate pEFnlsLacZ∆enh,
pEFnlsLagZ∆enh and pEFnlsLagoZ∆enh plasmids. The LacZ
reporter was also inserted by homologous recombination in
yeast at the same location into a 150 kb YAC spanning the
human EFIα locus (Figure 1a). Construction of plasmids and
YAC will be described elsewhere. The expression of the differ-
ent transgenes was controlled by transient expression exper-
iments that gave the same activity [24] as measured using
MUG quantification [29].
Transgenesis, recovery of embryonic and adult organs 
and cryosectioning
Each EF1α plasmid construct was first digested by the NotI
restriction enzyme and then partially digested using the XhoI
restriction enzyme to remove vector DNA sequences. The 7.9
kb XhoI/NotI inserts were purified and microinjected (200
copies/pl) into the male pronucleus one-cell embryo obtained
from (C57BL/6JxDBA2) F1 superovulated females mated
with males of the same strain. Five independent
YacEF1αLacZ, four independent EF1αLacZ, four independ-
ent EF1αLagZ and four independent EIFαLagoZ mouse lines
were analyzed in this study. All embryos and organs were X-
gal stained as described [30].
Real-time PCR on PE Biosystems Prism 7700
A TaqMan probe and primer set designed to amplify the
LacZ, LagZ and LagoZ transgenes and an internal control
(Rapsyn  gene) were used to determine transgene copy
number using DNA extracted from liver.
DNA preparation and methylation analysis
Tissues were collected from postnatal (P5) hemizygous mice
(liver, skin and brain) and from adult males (testis) using
standard protocol. Twenty micrograms of DNA were digested
with appropriate enzymes to liberate the fragments to be ana-
lyzed - either HpaII (methylation-sensitive) or MspI (methyl-
ation-insensitive). The DNA was analyzed by Southern
hybridization as previously described [31], probes for methyl-
ation are indicated in Figures 3 and 4.
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